BioAge Labs, Inc.
NASDAQ:BIOABiotechnology
+$0.47 today
- Market cap
- $179.59M
- Beta
- 0.95
- P/E (TTM)
- -9.7
- EPS (TTM)
- -$2.12
Volume 0.64M
Average 0.46M
BIOA Effect of Forex Changes
Change in reported cash caused by exchange-rate movements on foreign-currency balances.
BioAge Labs, Inc.NASDAQ: BIOA
Effect of Forex Changes · Q1 FY2026 · quarter ended Mar 2026
Effect of forex changes growth accelerates
Q1 FY2026 effect of forex changes of $27K (cash outflow) rose 125.0% year over year, ahead of the -304.0% change in trailing-twelve-month effect of forex changes. Sequentially, it rose 42.1% from the prior quarter.
Context
- Effect of forex changes amounted to 1.0% of revenue in FY2025.
- Effect of forex changes increased in 1 of the last 3 fiscal years.
- FY2025 was the lowest annual figure in the 4 fiscal years shown.
What to watch
Whether quarterly growth of +125.0% holds above the trailing-twelve-month pace of -304.0%.
Sources:Cash FlowText generated from reported figures; not investment advice.
Effect of Forex Changes history
USD · from the cash flow
- Latest · FY2025
- (87K) USD
- Year-over-year change
- -207.4%
| Period | Period end | Effect of Forex Changes | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | (87K) | -207.4% |
| FY2024 | 2024-12-31 | 81K | — |
| FY2023 | 2023-12-31 | 0 | -100.0% |
| FY2022 | 2022-12-31 | 246K | — |
Effect of Forex Changes vs competitors
How BIOA compares with its peers on the latest reported figures
- Peers report in different currencies, so effect of forex changes is compared through growth and share of revenue rather than absolute size.
- Its year-over-year change of -304.0% is the lowest of 4, against a peer median of -84.0%.
- Effect of forex changes amounts to 1.0% of revenue for BIOA, versus a peer median of 0.8%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Mar 2026 | $11.95M USD | — | — | 8.8% | |
| LTM Mar 2026 | CA$3.62M CAD | +1274.6% | -12.1% | 1.2% | |
| LTM Mar 2026 | CA$1.34M CAD | -84.0% | -51.7% | 0.4% | |
| LTM Mar 2026 | $144K USD | — | — | 7.1% | |
BIOABioAge Labs, Inc. | LTM Mar 2026 | $102K USD | -304.0% | — | 1.0% |
| LTM Mar 2026 | $1K USD | -92.3% | — | — | |
| LTM Mar 2026 | $0 USD | — | — | 0.0% | |
| LTM Mar 2026 | $0 USD | — | — | — | |
| LTM Mar 2026 | $0 USD | — | — | 0.0% | |
| LTM Mar 2026 | $0 USD | — | — | — | |
| Peer median (excluding BIOA) | — | -84.0% | -31.9% | 0.8% | |
Competitors are the stored peer set for BIOA. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Cash Flow Statement
BioAge Labs, Inc.
NASDAQ:BIOA
Intrinsic Alpha fair value
Locked
Current Price
$4.77
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.